Sinovac Biotech Co., Ltd.
Clinical trials sponsored by Sinovac Biotech Co., Ltd., explained in plain language.
Sinovac Biotech Co., Ltd.
SVA
NASDAQ
Vaccine developer and manufacturer, known for COVID-19 vaccine CoronaVac.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Polio vaccine showdown: which sequence protects best? Results expected Sep 2026 (estimated)
- Rabies vaccine batch check: will it pass the test? Results expected Sep 2026 (estimated) 🚀 Make-or-break
- New meningitis vaccine for kids shows promise in large trial Results expected Nov 2026 (estimated) 🚀 Make-or-break
- New meningitis vaccine for toddlers shows promise in major trial Results expected Jan 2027 (estimated) 🚀 Make-or-break
- Can a vaccine shield children from severe hand, foot, and mouth disease? Results expected Jan 2027 (estimated)